Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-25T08:07:39.771Z Has data issue: false hasContentIssue false
  • English
  • Français

La valutazione dei costi diretti ed indiretti della depressione maggiore: applicazione di una metodologia di indagine in un servizio psichiatrico pubblico

Published online by Cambridge University Press:  07 August 2014

Mauro Percudani ,
Giovanni Fattore ,
Loredana Strada  and
Agostino Contini
Mauro Percudani*
Affiliation:
Servizio di Psichiatria, Ospedale G. Fornaroli, Magenta (Milano)
Giovanni Fattore
Affiliation:
CeRGAS-SDA, Università L. Bocconi, Milano
Loredana Strada
Affiliation:
Servizio di Psichiatria, Ospedale G. Fornaroli, Magenta (Milano)
Agostino Contini
Affiliation:
Servizio di Psichiatria, Ospedale G. Fornaroli, Magenta (Milano)
*
Indirizzo per la corrispondenza: Dr. M. Percudani, Servizio di Psichiatria, CPS USSL 72, Via Fornaroli 67, 20013 Magenta (Milano).
Get access Rights & Permissions [Opens in a new window]

Summary

Objective - This study aims to improve the economic knowledge of major depression. It reports the investigation methodology and some preliminary indications on direct and indirect costs associated to this illness. Setting - Centro Psicosociale (CPS) USSL 72, Magenta (Mi) Italy. Design - We enrolled 10 patients (7F and 3M) with age between 34 and 65 (average 49.2 + 10.2 SD) at the first contact with CPS for an episode of major depression and we followed them up for 3 months. Main Measure Outcomes - At each visit we perform a clinical evaluation (HRS-D, CGI, DOTES) and we administered an interview to collect data in order to quantify social costs (direct and indirect) related to the observation period. Results - At the end of the 3 month period, all patients showed an improvement of the simptomatolgy as expressed by HRS-D (final score at least 50% below the initial one). Our accounting model estimated that the full cost of a psychiatric visit (on average lasting 47.8 minutes) is 107.537 Italian Liras. For the 10 patients under observation direct costs amounted to 9.402.000 It. Liras; psychiatric visits represented 70% of these costs. According to a conservative approach, indirect costs (value of labor time lost) amounted to 13.254.000 It. Liras if patients and relatives are considered and to 11.044.000 It. Liras if only patients time is evaluated. Conclusion - The paper presents a methodological proposal aimed to assess social costs of major depression. It also reports a first attempt to measure these costs in a prospective study performed in a public psychiatric centre. Our results have to be considered in the light of the limited sample of patients under observation and have to be regarded as strictly dependent on the specific context both in terms of the organizational settings and the characteristics of patients.

Keywords

major depressioneconomic evaluationburden of illnesseconomicscost analysisdepressione maggiorevalutazione economicacosti socialieconomiaanalisi dei costi.
Type
Articoli
Information
Epidemiology and Psychiatric Sciences , Volume 4 , Issue 3 , Settembre-Dicembre 1995 , pp. 198 - 211
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

BIBLIOGRAFIA

Altamura, A.C. & Percudani, M. (1993). The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies and future directions. Journal of Clinical Psychiatry 54, Suppl., 29–37.Google ScholarPubMed
Bellantuono, C. & Balestrieri, M. (1995). La valutazione dei costi del trattamento farmacologico nella depressione. Una revisione critica della letteratura. Epidemiologia e Psichiatria Sociale 4, 51–66.CrossRefGoogle Scholar
Borgonovi, E. (1988). L'impiego dell'analisi costi-benefici e dell'analisi costi-efficacia nell'allocazione delle risorse. In La Programmazione ed il Controllo nelle Strutture Sanitarie (ed. Meneguzzo, M., Zavattaro, F., Mazzoleni, M. e Borgonovi, E.). McGraw Hill: Milano.Google Scholar
Cavallo, M.C. & Fattore, G. (1994). Il costo sociale nella malattia di Alzheimer. Metodologia e risultati di una indagine preliminare. Mecosan 10, 12–23.Google Scholar
Drummond, M.F. (1980). Economie Appraisal in Health Care. Oxford University Press: Oxford.Google Scholar
Drummond, M.F., Stoddart, G.L. & Torrance, G.W. (1987). Methods for the Economie Evaluation of Health Care Programmes. Oxford University Press: Oxford.Google Scholar
Faravelli, C., Paterniti, S. & Taberna, A. (1994). Ansia e depressione nella popolazione generale. Epidemiologia e Psichiatria Sociale 3, 19–26.CrossRefGoogle Scholar
Fattore, G. (1994). SmithKline Beecham Investigator Meeting sullo studio di valutazione dei costi sociali della depressione maggiore. Roma 10.1.1994. Comunicazione personale.Google Scholar
Frank, R.G. & Kamlet, M.S. (1985). Direct costs and expenditures for mental health care in the United States in 1980. Hospital and Community Psychiatry 36, 165–168.Google ScholarPubMed
Gilchrist, S. & Knapp, M. (1994). Economics and mental health. Current Opinion in Psychiatry 7, 167–172.CrossRefGoogle Scholar
Grassi, A., Lenzi, M.R., Pettinicchi, M.C., Previdi, F. & Zuffi, R. (1992) Valutazione dei costi del trattamento non ospedaliero delle psicosi affettive. Neurologia Psichiatria e Scienze Umane 12, 287–295.Google Scholar
Greenberg, P.E., Stiglin, L.E., Finkelstein, S.L. & Berndt, E.R. (1993). The economie burden of depression in 1990. Journal of Clinical Psychiatry 54, 405–418.Google Scholar
Grey, A. & Fenn, P. (1993). Alzheimer's disease: the burden of the illness in England. Health Trends 25, 31–37.Google Scholar
Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. DHEW publication No. 76-338: Washington.Google Scholar
Hodgson, T.A. & Meiners, M.R. (1982). Cost-of-illness methodology: a guide to current practices and procedures. Millbank Memorial Fund Quarterly/Health and Society 60, 429–491.CrossRefGoogle ScholarPubMed
Informatore Farmaceutico. (1994). I Medicinali. OEMF: Milano.Google Scholar
Jonsson, B. & Bebbington, P.E. (1994). What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry 164, 655–673.CrossRefGoogle ScholarPubMed
Kind, P. & Sorensen, J. (1993). The costs of depression. International Clinical Psychopharmacology 7, 191–195.CrossRefGoogle ScholarPubMed
McGuire, T. (1991). Measuring the economic costs of schizophrenia. Schizophrenia Bullettin 17, 421–426.Google ScholarPubMed
McGuire, A. & Drummond, M. (1993). Economic evaluation in health care: an introduction for psychiatrists. Social Psychiatry and Psychiatric Epidemiology 28, 211–217.CrossRefGoogle ScholarPubMed
Ministero del Lavoro e della Previdenza Sociale (1992). Rapporto '90/'91. Lavoro e Politiche della Occupazione in Italia. Roma.Google Scholar
Moscarelli, M., Capri, S. & Neri, L. (1991). Cost evaluation of chronic schizophrenic patients during the first 3 years after first contact. Schizophrenia Bullettin 17, 421–426.CrossRefGoogle ScholarPubMed
Rice, D.P., Kelman, S. & Miller, L.S. (1992). The economic burden of mental illness. Hospital and Community Psychiatry 43, 1227–1232.Google ScholarPubMed
Sartorius, N. & Ustun, T.B. (1995). Mental illness in Primary Care. An International Study. John Wiley and Sons: New York.Google Scholar
Stoudemire, A., Frank, R., Hedemark, N., Kamlet, M. & Balzer, D. (1986). The economic burden of depression. General Hospital Psychiatry 8, 387–394.CrossRefGoogle ScholarPubMed
West, R. (1992). Depression. Office of Health Economics: London.Google Scholar